Published in Diagn Microbiol Infect Dis on February 20, 2013
Specialized Proresolving Mediators in Pneumocystis Jirovecii Pneumonia (INFLA-PCP) | NCT03606252
Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006). Crit Care Med (2009) 3.07
Genotype of 88 Toxoplasma gondii isolates associated with toxoplasmosis in immunocompromised patients and correlation with clinical findings. J Infect Dis (2009) 2.33
Quantification and spread of Pneumocystis jirovecii in the surrounding air of patients with Pneumocystis pneumonia. Clin Infect Dis (2010) 1.41
Strain typing methods and molecular epidemiology of Pneumocystis pneumonia. Emerg Infect Dis (2004) 1.12
A cluster of Pneumocystis infections among renal transplant recipients: molecular evidence of colonized patients as potential infectious sources of Pneumocystis jirovecii. Clin Infect Dis (2012) 1.10
Genotypes at the internal transcribed spacers of the nuclear rRNA operon of Pneumocystis jiroveci in nonimmunosuppressed infants without severe pneumonia. J Clin Microbiol (2003) 1.06
Lack of standardization in the procedures for mycological examination of sputum samples from CF patients: a possible cause for variations in the prevalence of filamentous fungi. Med Mycol (2010) 1.06
Transient aspergillus antigenaemia: think of milk. Lancet (2002) 1.03
Evaluation of four commercial rapid immunochromatographic assays for detection of Cryptosporidium antigens in stool samples: a blind multicenter trial. J Clin Microbiol (2011) 1.02
[Therapy of leishmaniasis in France: consensus on proposed guidelines]. Presse Med (2010) 1.00
Pneumocystis jirovecii dihydropteroate synthase genotypes in immunocompetent infants and immunosuppressed adults, Amiens, France. Emerg Infect Dis (2004) 0.97
Presence of Enterocytozoon bieneusi associated with intestinal coccidia in patients with chronic diarrhea visiting an HIV center in Haiti. Am J Trop Med Hyg (2008) 0.95
[Human cryptosporidiosis and Cryptosporidium spp. in Haiti]. Trop Med Int Health (2006) 0.94
Apparent absence of Pneumocystis jirovecii in healthy subjects. Clin Infect Dis (2006) 0.94
The placenta: a main role in congenital toxoplasmosis? Trends Parasitol (2011) 0.94
Combined quantification of pulmonary Pneumocystis jirovecii DNA and serum (1->3)-β-D-glucan for differential diagnosis of pneumocystis pneumonia and Pneumocystis colonization. J Clin Microbiol (2013) 0.93
Pneumocystis jiroveci internal transcribed spacer types in patients colonized by the fungus and in patients with pneumocystosis from the same French geographic region. J Clin Microbiol (2003) 0.93
Longitudinal study assessing the return of chloroquine susceptibility of Plasmodium falciparum in isolates from travellers returning from West and Central Africa, 2000-2011. Malar J (2013) 0.93
Dynamics of Pneumocystis carinii air shedding during experimental pneumocystosis. J Infect Dis (2011) 0.92
Indoor fungal contamination: health risks and measurement methods in hospitals, homes and workplaces. Crit Rev Microbiol (2013) 0.92
Clinical relevance of placenta examination for the diagnosis of congenital toxoplasmosis. Pediatr Infect Dis J (2010) 0.91
Near-fatal multiple organ dysfunction syndrome induced by Plasmodium malariae. Emerg Infect Dis (2009) 0.91
Bacterial and fungal counts in hospital air: comparative yields for 4 sieve impactor air samplers with 2 culture media. Infect Control Hosp Epidemiol (2006) 0.91
Impaired functions of macrophage from cystic fibrosis patients: CD11b, TLR-5 decrease and sCD14, inflammatory cytokines increase. PLoS One (2013) 0.87
Similar genotypes of Pneumocystis jirovecii in different forms of Pneumocystis infection. Microbiology (2004) 0.87
VOC contamination in hospital, from stationary sampling of a large panel of compounds, in view of healthcare workers and patients exposure assessment. PLoS One (2013) 0.87
High level of soluble HLA-G in amniotic fluid is correlated with congenital transmission of Toxoplasma gondii. Clin Immunol (2010) 0.87
Immunocompetent infants as a human reservoir for Pneumocystis jirovecii: rapid screening by non-invasive sampling and real-time PCR at the mitochondrial large subunit rRNA gene. J Eukaryot Microbiol (2003) 0.86
Invariant NKT cells drive hepatic cytokinic microenvironment favoring efficient granuloma formation and early control of Leishmania donovani infection. PLoS One (2012) 0.86
Correlation of parasite load determined by quantitative PCR to clinical outcome in a heart transplant patient with disseminated toxoplasmosis. J Clin Microbiol (2010) 0.85
Possible nosocomial transmission of Pneumocystis jirovecii. Emerg Infect Dis (2012) 0.84
Comparison of the immunomodulatory effects of L. donovani and L. major excreted-secreted antigens, particulate and soluble extracts and viable parasites on human dendritic cells. Vaccine (2008) 0.84
Anti-inflammatory effect of fluvastatin on IL-8 production induced by Pseudomonas aeruginosa and Aspergillus fumigatus antigens in cystic fibrosis. PLoS One (2011) 0.83
Correlation between Environmental Relative Moldiness Index (ERMI) values in French dwellings and other measures of fungal contamination. Sci Total Environ (2012) 0.83
Pneumocystis jirovecii genotypes involved in pneumocystis pneumonia outbreaks among renal transplant recipients. Clin Infect Dis (2012) 0.83
Serum (1->3)-beta-D-glucan levels in primary infection and pulmonary colonization with Pneumocystis jirovecii. J Clin Microbiol (2011) 0.83
Comparison of albicans vs. non-albicans candidemia in French intensive care units. Crit Care (2010) 0.82
Pneumocystis jiroveci genotypes and primary infection. Clin Infect Dis (2003) 0.80
Pneumocystis jirovecii and cystic fibrosis in France. Scand J Infect Dis (2010) 0.80
Indoleamine 2,3-dioxygenase activity as a potential biomarker of immune suppression during visceral leishmaniasis. Innate Immun (2013) 0.79
Serologic screening for Neospora caninum, France. Emerg Infect Dis (2009) 0.79
Pneumocystis jirovecii airborne transmission between critically ill patients and health care workers. Intensive Care Med (2015) 0.79
Hypothetical Pneumocystis jirovecii transmission from immunocompetent carriers to infant. Emerg Infect Dis (2009) 0.78
Evaluation of DPC immulite 2000 Toxoplasma quantitative IgG/IgM kits for automated toxoplasmosis serology with immulite 2000. J Clin Lab Anal (2009) 0.78
Use of denaturing high-performance liquid chromatography (DHPLC) to characterize the bacterial and fungal airway microbiota of cystic fibrosis patients. J Microbiol (2014) 0.78
Immunostimulatory properties of dendritic cells after Leishmania donovani infection using an in vitro model of liver microenvironment. PLoS Negl Trop Dis (2010) 0.78
[Saccharomyces boulardii fungal sepsis: beware of the yeast]. Can J Anaesth (2007) 0.77
Multilocus genotyping of Pneumocystis jirovecii in patients developing diverse forms of parasitism: implication for a wide human reservoir for the fungus. J Eukaryot Microbiol (2003) 0.77
Synthetic UDP-furanoses inhibit the growth of the parasite Leishmania. Carbohydr Res (2010) 0.77
Recurrent American cutaneous leishmaniasis. Emerg Infect Dis (2007) 0.77
Alkyl galactofuranosides strongly interact with Leishmania donovani membrane and provide antileishmanial activity. Antimicrob Agents Chemother (2014) 0.77
Cryptosporidium hominis and Isospora belli diarrhea in travelers returning from West Africa. J Travel Med (2010) 0.76
Pneumocystis jirovecii genotypes in European patients with chronic obstructive pulmonary diseases. J Eukaryot Microbiol (2006) 0.76
Outbreak of Leishmania braziliensis Cutaneous Leishmaniasis, Saül, French Guiana. Emerg Infect Dis (2015) 0.75
Circulation of Pneumocystis dihydropteroate synthase mutants in France. Diagn Microbiol Infect Dis (2012) 0.75
Can we describe the epidemiology of candidemia without using selective blood culture bottles for fungus detection? Clin Infect Dis (2004) 0.75
Severe Pneumocystis pneumonia in a renal transplant recipient after long term mycophenolate mofetil treatment. Rev Inst Med Trop Sao Paulo (2005) 0.75
Cryptosporidiosis in Haiti: surprisingly low level of species diversity revealed by molecular characterization of Cryptosporidium oocysts from surface water and groundwater. Parasite (2013) 0.75
Prevention of nosocomial fungal infection: the French approach. Clin Infect Dis (2002) 0.75
Leishmania cell wall as a potent target for antiparasitic drugs. A focus on the glycoconjugates. Org Biomol Chem (2015) 0.75
Evaluation of a new mobile system for protecting immune-suppressed patients against airborne contamination. Am J Infect Control (2007) 0.75
Molecular typing of Pneumocystis jirovecii in a patient from French Guiana. Mycoses (2010) 0.75
Epidemiology of Trichophyton verrucosum infection in Rennes University Hospital, France: A 12-year retrospective study. Med Mycol (2017) 0.75
Photo quiz: A 39-year-old man with human immunodeficiency virus infection presenting with an alveolo-interstitial pulmonary syndrome. J Clin Microbiol (2013) 0.75
Be aware of imported but also autochthonous myiasis. J Travel Med (2003) 0.75